Checkpoint inhibition—especially via anti-PD-1 antibodies—has been associated with a transition from an immune-excluded to a more inflamed phenotype, characterized by the migration of clonally expanded CD8+ T cells from the stromal compartment into tumor epithelial regions [76]. The gene discussed is CD8A; the disease is neoplasm.